MedPath

Three Good Things 2020: a Brief Text-based Wellness Intervention

Not Applicable
Completed
Conditions
Job Related Stress
Interventions
Behavioral: Three Good Things
Behavioral: Wait list control arm and then Three Good Things
Registration Number
NCT04676698
Lead Sponsor
University of Michigan
Brief Summary

This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff.

The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention.

At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
223
Inclusion Criteria
  • Faculty, resident, or staff in the Michigan Medicine (MM) Department of Family Medicine
Read More
Exclusion Criteria
  • Not a member of Family Medicine at MM
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Three Good ThingsThree Good ThingsThree times weekly for three weeks, participants will receive a text-based survey asking them to type or dictate "three good things."
Waitlist Control Arm then Three Good ThingsWait list control arm and then Three Good ThingsParticipants will have surveys in the waiting period for 3 months and then be crossed over to the treatment arm Three Good Things.
Primary Outcome Measures
NameTimeMethod
Change in the Positive and Negative Affect Schedule (PANAS-SF) between the intervention and control groupPre-Treatment (baseline), up to 6 months

This is a 10 item survey to measure positive and negative affect. Responses include; very slightly or not at all, a little, quite a bit, and extremely. Higher scores of Positive Affect (PA) subscale represent higher positive affect higher scores of Negative affect (NA) subscale represent higher negative affect.

Secondary Outcome Measures
NameTimeMethod
Change in Satisfaction with Life QuestionnairePre-Treatment (baseline), up to 6 months

This is a 5 question questionnaire in which participants select from 7 responses that are given a 1-7 scale from strongly disagree to strongly agree. Scoring ranges from 5-35 where 20 = neutral (the higher the score the more satisfaction).

Change in Gratitude using the Gratitude Adjective Checklist (GAC)Pre-Treatment (baseline), up to 6 months

The GAC is a 3-item self-report measure of state gratitude in which participants select, (1) A little (2) Moderately, Quite a bit (4), and Extremely (5).The total score on GAC ranges from 3 to 15, with higher score indicating greater state gratitude.

Change in self-reported physical healthPre-Treatment (baseline), up to 6 months

This is a 1 question item to assess participants physical health ( 1=Excellent 2=good 3=fair 4=poor).

Change in self-reported mental healthPre-Treatment (baseline), up to 6 months

This is a 1 question item to assess participants mental health ( 1=Excellent 2=good 3=fair 4=poor).

Change in depression using the Patient Health Questionnaire 9-item (PHQ-9) scorePre-Treatment (baseline) to 6 months

PHQ-9 scores reflect depression severity. Participants will select responses that include 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Ranges in scores are from 0-27 (Scores: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe).

Change in the Hope ScalePre-Treatment (baseline), up to 6 months

This is a 12 item questionnaire in which participants select from answers that include 1=definitely false 2=mostly false 3=mostly true 4=definitely true.

Scores range from 12-48 with higher scores indicating greater hope.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath